Shah Capital Management
Source: SEC Form 13F · as of Mar 2026Shah Capital Management holds 1 biotech & pharma company tracked by BioSniper, totaling $120.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
1
Total value held
$120.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for NOVAVAX INC (NVAX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NVAXNOVAVAX INC | 14,845,097 | $120.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.